Xoma Corporation Preferred Stock Today

XOMAO Preferred Stock  USD 25.36  0.09  0.36%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 9

 
High
 
Low
Low
XOMA is selling at 25.36 as of the 28th of November 2024; that is 0.36% increase since the beginning of the trading day. The preferred stock's open price was 25.27. XOMA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for XOMA Corporation are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. More on XOMA Corporation

Moving against XOMA Preferred Stock

  0.81FNCH Finch TherapeuticsPairCorr
  0.78HRGN Harvard ApparatusPairCorr
  0.73CEROW CERo Therapeutics Symbol ChangePairCorr
  0.69ENSCW Ensysce BiosciencesPairCorr
  0.62EMMA Emmaus Life SciencesPairCorr
  0.61CYCCP Cyclacel PharmaceuticalsPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

XOMA Preferred Stock Highlights

ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, XOMA's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to XOMA's managers, analysts, and investors.
Environmental
Governance
Social
Business ConcentrationPharmaceutical Products, Biotechnology, Healthcare, Biotechnology, Healthcare (View all Sectors)
XOMA Corporation (XOMAO) is traded on NASDAQ Exchange in USA. It is located in 2200 Powell Street, EmeryVille, CA, United States, 94608 and employs 12 people. XOMA is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Biotechnology industry. XOMA Corporation has accumulated about 83.7 M in cash with 22.68 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.31.
Check XOMA Probability Of Bankruptcy

XOMA Risk Profiles

XOMA Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in XOMA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

Other Information on Investing in XOMA Preferred Stock

XOMA financial ratios help investors to determine whether XOMA Preferred Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XOMA with respect to the benefits of owning XOMA security.